171 related articles for article (PubMed ID: 29033552)
1. Therapy preferences of patients with lung and colon cancer: a discrete choice experiment.
Schmidt K; Damm K; Vogel A; Golpon H; Manns MP; Welte T; Graf von der Schulenburg JM
Patient Prefer Adherence; 2017; 11():1647-1656. PubMed ID: 29033552
[TBL] [Abstract][Full Text] [Related]
2. What matters most to patients with multiple myeloma? A Pan-European patient preference study.
Janssens R; Lang T; Vallejo A; Galinsky J; Morgan K; Plate A; De Ronne C; Verschueren M; Schoefs E; Vanhellemont A; Delforge M; Schjesvold F; Cabezudo E; Vandebroek M; Stevens H; Simoens S; Huys I
Front Oncol; 2022; 12():1027353. PubMed ID: 36523996
[TBL] [Abstract][Full Text] [Related]
3. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
Mühlbacher AC; Nübling M
Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
[TBL] [Abstract][Full Text] [Related]
4. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
[TBL] [Abstract][Full Text] [Related]
5. Older adults' preferences for colorectal cancer-screening test attributes and test choice.
Kistler CE; Hess TM; Howard K; Pignone MP; Crutchfield TM; Hawley ST; Brenner AT; Ward KT; Lewis CL
Patient Prefer Adherence; 2015; 9():1005-16. PubMed ID: 26203233
[TBL] [Abstract][Full Text] [Related]
6. Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.
Fernández O; Lázaro-Quintela M; Crespo G; Soto de Prado D; Pinto Á; Basterretxea L; Gómez de Liaño A; Etxaniz O; Blasco S; Gabás-Rivera C; Aceituno S; Palomar V; Polanco-Sánchez C
Front Oncol; 2021; 11():773366. PubMed ID: 35070976
[TBL] [Abstract][Full Text] [Related]
7. Assessment of patients' preferences for new anticancer drugs in China: a best-worst discrete choice experiment on three common cancer types.
Feng Z; Meng J; Sun Y; Xie T; Lu W; Wang G; Geng J
BMJ Open; 2023 Jun; 13(6):e072469. PubMed ID: 37270199
[TBL] [Abstract][Full Text] [Related]
8. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
9. Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective.
Johnston KM; Audhya IF; Dunne J; Feeny D; Neumann P; Malone DC; Szabo SM; Gooch KL
Appl Health Econ Health Policy; 2024 May; 22(3):343-352. PubMed ID: 38253973
[TBL] [Abstract][Full Text] [Related]
10. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
[TBL] [Abstract][Full Text] [Related]
11. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
[TBL] [Abstract][Full Text] [Related]
12. Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study.
Teng Y; Wei Y; Chen Y; Yan J; Liu S; Li F; Bao S; Ren Y; Liu L; Yang Y
Integr Med Res; 2023 Sep; 12(3):100969. PubMed ID: 37546234
[TBL] [Abstract][Full Text] [Related]
13. Chronic pain patients' treatment preferences: a discrete-choice experiment.
Mühlbacher AC; Junker U; Juhnke C; Stemmler E; Kohlmann T; Leverkus F; Nübling M
Eur J Health Econ; 2015 Jul; 16(6):613-28. PubMed ID: 24950770
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment.
Brinkmann M; Diedrich L; Hemmerling M; Krauth C; Robra BP; Stahmeyer JT; Dreier M
Value Health; 2023 Jan; 26(1):104-114. PubMed ID: 36031478
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Evaluating patients' preferences for multiple myeloma therapy, a Discrete-Choice-Experiment.
Mühlbacher AC; Lincke HJ; Nübling M
Psychosoc Med; 2008 Dec; 5():Doc10. PubMed ID: 19742282
[TBL] [Abstract][Full Text] [Related]
17. Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.
Mühlbacher AC; Bethge S
Pharmacoeconomics; 2015 Jan; 33(1):71-81. PubMed ID: 25342231
[TBL] [Abstract][Full Text] [Related]
18. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
[TBL] [Abstract][Full Text] [Related]
19. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
[TBL] [Abstract][Full Text] [Related]
20. Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.
Cornelissen D; Boonen A; Bours S; Evers S; Dirksen C; Hiligsmann M
Osteoporos Int; 2020 Jan; 31(1):85-96. PubMed ID: 31606825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
